Results 211 to 220 of about 97,918 (341)
The potential of nanomedicine therapies to treat neovascular disease in the retina
Krysten M. Farjo, Jian‐xing Ma
openalex +2 more sources
SeNSs provide a biocompatible, anti‐inflammatory UC therapy. SeNSs form protein coronas enriched with AKT/PI3K/NF‐κB pathway proteins, suppress GP130 via hydrophobic interactions, and inhibit pro‐inflammatory cytokines. In DSS‐induced UC mice, SeNSs reduce inflammation, tissue damage, and disease activity by modulating cytokine, chemokine, and ...
Dingyi Shen+5 more
wiley +1 more source
Summary: Increasing evidence indicates that immunotherapy is hindered by a hostile tumor microenvironment (TME) featured with deprivation of critical nutrients and pooling of immunosuppressive metabolites.
Jieyu Liu+4 more
doaj
Hiding in Plain Sight: Cell Biomimicry for Improving Hematological Cancer Outcomes. [PDF]
Weinstein LA, Wei B.
europepmc +1 more source
Nanomedicine: Optical Nanomanipulations of Malignant Cells: Controlled Cell Damage and Fusion (Small 11/2012) [PDF]
Limor Minai+5 more
openalex +1 more source
Nanomedicine‐Driven Modulation of Reductive Stress for Cancer Therapy
This article introduces a novel therapeutic paradigm that deliberately induces reductive stress within tumor cells to exploit their unique biochemical vulnerabilities. It systematically reviews the underlying biological mechanisms, current detection and monitoring techniques, and emerging advanced nanotechnology platforms specifically designed to ...
Yumin Mao+8 more
wiley +1 more source
Nanomedicine-Enhanced Radiotherapy for Glioblastoma: Advances in Targeted Therapy and Adaptive Treatment Strategies. [PDF]
Rawojć K+4 more
europepmc +1 more source
Toward personalized cancer nanomedicine – past, present, and future [PDF]
Alexander H. Stegh
openalex +1 more source
Delivering nanomedicine to solid tumors
R. Jain, T. Stylianopoulos
semanticscholar +1 more source